Share on StockTwits

Shares of Catamaran Corp (NASDAQ:CTRX) have earned a consensus rating of “Buy” from the fourteen ratings firms that are presently covering the company, AnalystRatings.Net reports. Six analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $60.36.

CTRX has been the subject of a number of recent research reports. Analysts at Citigroup Inc. initiated coverage on shares of Catamaran Corp in a research note on Tuesday, February 18th. They set a “neutral” rating on the stock. Separately, analysts at Argus initiated coverage on shares of Catamaran Corp in a research note on Wednesday, January 22nd. They set a “buy” rating and a $65.00 price target on the stock. Finally, analysts at Goldman Sachs downgraded shares of Catamaran Corp from a “buy” rating to a “neutral” rating in a research note on Tuesday, December 17th. They now have a $50.00 price target on the stock, down previously from $61.00.

Catamaran Corp (NASDAQ:CTRX) traded up 0.48% on Wednesday, hitting $52.57. 570,302 shares of the company’s stock traded hands. Catamaran Corp has a 1-year low of $43.49 and a 1-year high of $58.73. The stock has a 50-day moving average of $49.85 and a 200-day moving average of $49.52. The company has a market cap of $10.845 billion and a price-to-earnings ratio of 46.76.

Catamaran Corporation (NASDAQ:CTRX), formerly SXC Health Solutions Corp.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.